LRRK2 regulates production of reactive oxygen species in cell and animal models of Parkinson's disease

• Published in: Science translational medicine 2024-10, Vol.16 (767), p.eadl3438
• Main Authors: Keeney, Matthew T, Rocha, Emily M, Hoffman, Eric K, Farmer, Kyle, Di Maio, Roberto, Weir, Julie, Wagner, Weston G, Hu, Xiaoping, Clark, Courtney L, Castro, Sandra L, Scheirer, Abigail, Fazzari, Marco, De Miranda, Briana R, Pintchovski, Sean A, Shrader, William D, Pagano, Patrick J, Hastings, Teresa G, Greenamyre, J Timothy
• Format: Article
• Language: English
• Subjects: Animal models; Animals; Cell culture; CRISPR; CYBB protein; Cytosol; Disease Models, Animal; Dopamine receptors; Enzyme inhibitors; HEK293 Cells; Humans; Kinases; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 - genetics; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 - metabolism; Lipid Peroxidation; LRRK2 protein; Macrophages; Mesencephalon; Mice; Movement disorders; NAD(P)H oxidase; NADPH Oxidase 2 - genetics; NADPH Oxidase 2 - metabolism; NADPH Oxidases; Neurodegenerative diseases; Neurotoxicity; Oxidative stress; Oxidative Stress - drug effects; Parkinson Disease - genetics; Parkinson Disease - metabolism; Parkinson Disease - pathology; Parkinson's disease; Phosphorylation; Phosphorylation - drug effects; Rats; Rats, Sprague-Dawley; RAW 264.7 Cells; Reactive oxygen species; Reactive Oxygen Species - metabolism; Rotenone; Rotenone - pharmacology; Substantia nigra
• ISSN: 1946-6234; 1946-6242; 1946-6242; 1946-3242
• DOI: 10.1126/scitranslmed.adl3438

Oxidative stress has long been implicated in Parkinson's disease (PD) pathogenesis, although the sources and regulation of reactive oxygen species (ROS) production are poorly defined. Pathogenic mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) are associated with increased kinase activity and a greater risk of PD. The substrates and downstream consequences of elevated LRRK2 kinase activity are still being elucidated, but overexpression of mutant LRRK2 has been associated with oxidative stress, and antioxidants reportedly mitigate LRRK2 toxicity. Here, using CRISPR-Cas9 gene-edited HEK293 cells, RAW264.7 macrophages, rat primary ventral midbrain cultures, and PD patient-derived lymphoblastoid cells, we found that elevated LRRK2 kinase activity was associated with increased ROS production and lipid peroxidation and that this was blocked by inhibitors of either LRRK2 kinase or NADPH oxidase 2 (NOX2). Oxidative stress induced by the pesticide rotenone was ameliorated by LRRK2 kinase inhibition and was absent in cells devoid of LRRK2. In a rat model of PD induced by rotenone, a LRRK2 kinase inhibitor prevented the lipid peroxidation and NOX2 activation normally seen in nigral dopaminergic neurons in this model. Mechanistically, LRRK2 kinase activity was shown to regulate phosphorylation of serine-345 in the p47 subunit of NOX2. This, in turn, led to translocation of p47 from the cytosol to the membrane-associated gp91 (NOX2) subunit, activation of the NOX2 enzyme complex, and production of ROS. Thus, LRRK2 kinase activity may drive cellular ROS production in PD through the regulation of NOX2 activity.